Jump to main content
Jump to site search

All chapters

Subject Index

absorption, distribution, metabolism and excretion (ADME) properties, 231–233 activity-based probe (ABP), 75 acute myeloid leukemia (AML), 67 adverse effects, 246 afatinib, 68–70, 292 affinity based protein profiling (ABPP), 23 Akt1 inhibitors, 51 Akt inhibitors, 37–38 alectinib, 297 allosteric AUR...

Publication details


Print publication date
06 Nov 2018
Copyright year
2019
Print ISBN
978-1-78801-083-2
PDF eISBN
978-1-78801-309-3
From the book series:
Drug Discovery